insights_auto
Bakit bumaba ang ALNOV 4.66%?
Tingnan ang Higit pang Detalyechevron_right
ALNOV:EPA
Novacyt SA
€0.45
arrow_downward
-4.66%(-0.022) 1D
Okt 2, 5:35:11 PM GMT+2 · EUR
search
Lahat ng simbolo
| Simbolo | Presyo | Palitan | % ng Pagbabago |
|---|
insights_autoBumubuo ng mga nangungunang insight para sa ALNOV...
Buksan
€0.46
Mataas
€0.47
Mababa
€0.44
Mkt. cap
30.08M
Avg. na dami
259.52K
Dami
271.08K
Mataas nang 52-wk
€1.04
Mababa nang 52-wk
€0.29
EPS
-€0.39
Mga natitirang share
72.59M
Bilang ng mga empleyado
216
Buksan
€0.46
Mataas
€0.47
Mababa
€0.44
Mkt. cap
30.08M
Avg. na dami
259.52K
Dami
271.08K
Mataas nang 52-wk
€1.04
Mababa nang 52-wk
€0.29
EPS
-€0.39
Mga natitirang share
72.59M
Bilang ng mga empleyado
216
Mga balita at kwento
Mula sa mga source sa web at partner sa balita
24/7 Wall St.
·
2 araw ang nakalipas
The Stock Market Has Done This Only Once Before in the Last 156 Years. What Happens Next Gets Ugly Fast.
24/7 Wall St.
·
6 oras ang nakalipas
Why Pay to Own U.S. Stocks? This Zero-Fee ETF Is Beating the S&P 500
MarketWatch
·
6 araw ang nakalipas
Micron could dethrone Nvidia and become the biggest driver of S&P 500 profit growth
Reuters
·
1 buwan ang nakalipas
S&P 500, Nasdaq end down on tech stocks, investors weigh Iran moves
Profile
Novacyt Group is an Anglo-French biotechnology group focused on clinical diagnostics, with offices in Camberley, Surrey, United Kingdom and Vélizy-Villacoublay, France. The company produces in vitro and molecular diagnostic tests, supplying assays and reagents worldwide. Its business units include Primerdesign, Microgen Bioproducts and Lab21 Healthcare.
In January 2020 the company announced that its molecular diagnostics division, Primerdesign, had launched a molecular test for the 2019 strain of SARSr-CoV. The test was approved as eligible for procurement under the World Health Organization's Emergency Use Listing process in April 2020, meaning that the test could be supplied by the United Nations and other procurement agencies supporting the COVID-19 response. In the same month Novacyt announced a collaboration with AstraZeneca, GlaxoSmithKline and the University of Cambridge to support the UK in its COVID-19 national screening programme at a new testing laboratory at the university's Anne McLaren laboratory. Wikipedia
Tungkol sa Novacyt SA